Outcomes of invasive zygomycosis infections in renal transplant recipients

Transplant Infectious Disease

Volumn 9, Issue 2, 2007, Pages 161-164

  Forrest, G N ^a   Mankes, K ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Amphotericin B lipid complex; Renal transplantation; Zygomycosis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BIOPSY; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DEBRIDEMENT; DIABETES MELLITUS; DIAGNOSTIC VALUE; DRUG MEGADOSE; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LONG TERM CARE; LUNG INFECTION; MALE; MUCORMYCOSIS; ORBIT INFECTION; PARANASAL SINUS DISEASE; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; DRUG COMBINATIONS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; RETROSPECTIVE STUDIES; RISK FACTORS; ZYGOMYCOSIS;

EID: 34247585762     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2006.00197.x     Document Type: Article

References (16)

1. Perfect JR. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis 2005 40 (Suppl 6): S401 S408.
2. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000 30: 851 856.
3. Kauffman CA. Zygomycosis: reemergence of an old pathogen. Clin Infect Dis 2004 39: 588 590.
4. Linden PK. Amphotericin B lipid complex for the treatment of invasive fungal infections. Expert Opin Pharmacother 2003 4: 2099 2110.
5. Gonzalez CE, Couriel DR, Walsh TJ. Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Clin Infect Dis 1997 24: 192 196.
6. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002 34: 909 917.
7. Kauffman CA, Hedderwick S. Opportunistic fungal infections: filamentous fungi and cryptococcosis. Geriatrics 1997 52: 40 49.
8. Larkin JA, Montero JA. Efficacy and safety of amphotericin B lipid complex for zygomycosis. Infect Med 2003 20: 201 206.
9. Crompton JA, Alexander D, Somerville T, Shihab FS. Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient. Transpl Infect Dis 2004 6: 183 187.
10. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002 34: 7 14.
11. Nucci M. Emerging moulds: fusarium, scedosporium and zygomycetes in transplant recipients. Curr Opin Infect Dis 2003 16: 607 612.
12. Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003 37: 221 229.
13. Linden P, Williams P, Chan KM. Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections. Clin Transplant 2000 14: 329 339.
14. Herbrecht R, Letscher-Bru V, Bowden RA, et al. Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis 2001 20: 460 466.
15. McNab AA, McKelvie P. Iron overload is a risk factor for zygomycosis. Arch Ophthalmol 1997 115: 919 921.
16. MacDonald ML, Weiss PJ, Deloach-Banta LJ, Comer SW. Primary cutaneous mucormycosis with a Mucor specie: is iron overload a factor? Cutis 1994 54: 275 278.